Lakewood-Amedex Biotherapeutics, Inc. (LABT)

2.22 +0.17 (+8.29%) USD  |  NASDAQ  |  Sep 11, 16:00
2.15 -0.07 (-3.15%) Pre-Market: 09:03
More

Lakewood-Amedex Biotherapeutics EV to CFO

EV to CFO Chart

View EV to CFO for LABT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical EV to CFO Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 --

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Anixa Biosciences, Inc. Upgrade

EV to CFO Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade